1. TFOS Ambassadors

Peru

Guillermo Vera-Duarte

Dr. Guillermo Raúl Vera-Duarte completed his Ophthalmology residency at the Cátedra de Oftalmología, Universidad Nacional de Asunción (UNA) in Paraguay, and his fellowship training in Cornea, External Disease and Refractive Surgery at the Instituto de Oftalmología Fundación Conde de Valenciana in Mexico City, one of the leading referral and academic centers in Latin America. He earned his medical degree from Universidad Nacional de Asunción, where he began his early clinical and research involvement in anterior segment and ocular surface disorders. Dr. Vera-Duarte currently serves as Deputy Director and member of the Research Department at Oftalmosalud Eye Institute in Lima, Peru. He is also an Assistant Tutor at the Cátedra de Oftalmología of Universidad Nacional de Asunción and collaborates with the Fundación Banco de Ojos Oca del Valle. His main areas of clinical and academic interest include corneal transplantation, ocular surface disease, and refractive surgery, with a particular focus on dry eye disease, neurotrophic keratopathy, allergic keratoconjunctivitis, keratoconus, and anterior segment surgical innovation. His work integrates clinical and translational research, emphasizing personalized approaches and optimizing diagnostic and surgical techniques. He has co-authored several peer-reviewed publications and review articles in international journals, including studies on corneal neurotization, immunomodulatory therapies for ocular surface inflammation, limbal stem cell deficiency, and intraocular lens power calculation after refractive surgery. Dr. Vera-Duarte also participates in multicenter collaborations across Latin America, aiming to strengthen regional research capacity and promote standardized clinical protocols for ocular surface disease. In addition to his clinical and research work, he is deeply involved in resident education, curriculum development, and academic mentorship in cornea and refractive surgery. He frequently participates as a lecturer and panelist in national and international ophthalmology meetings.  
 
< back

20 April

TFOS Guidelines

Ocular surface disease (OSD)—including dry eye disease, blepharitis, meibomian gland dysfunction, conjunctival inflammation, and cicatrizing ocular surface disorders—is one of the most common and underrecognized factors affecting the success of eye surgery (e.g., refractive, cataract, glaucoma, strabismus, retina, and oculoplastic). Conversely, optimizing the ocular surface is one of the most effective, modifiable strategies for enhancing surgical success across all ophthalmic subspecialties. And the central clinical principle appears to be universal: elective eye surgery...

17 April

EssilorLuxottica Partners with TFOS to Advance Ocular Surface Health Worldwide

TFOS is pleased to announce a new strategic partnership with EssilorLuxottica, a global leader in vision care and eyewear. This collaboration will support shared efforts to elevate awareness, education, and scientific progress in tear film and ocular surface health worldwide. By combining TFOS’s expertise in evidence-based consensus and professional education with EssilorLuxottica’s global reach and innovation capabilities, the partnership aims to help improve standards of care for patients affected by dry eye disease and related ocular surface conditions. Together, TFOS and EssilorLuxottica...

10 February

Latin American TFOS Ambassador Meeting

TFOS has organized a special meeting of the Latin American TFOS Ambassadors. This meeting, which will occur in Panama City this May, has two goals: first, to address the unmet needs for the management (e.g. diagnosis & treatment) of ocular surface diseases in their country/region, as well as what the Ambassadors perceive as short and long term scientific/clinical solutions; and second, to create a report for publication in a peer-reviewed journal. Participants will include TFOS Ambassadors from Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, Guatemala, Honduras,...

Corporate Advisory Board Members